Agility Clinical Expands Consulting Services

Agility Clinical has expanded its consulting services to aid small and virtual biopharma and device companies. Agility helps preclinical and clinical stage companies that have a lean infrastructure to develop drugs and devices by providing strategic and operational consulting support, in addition to traditional CRO services.
 
Agility has added resources to its consulting offering which covers all stages of clinical development from regulatory strategy to electronic submission, including expertise in chemistry, manufacturing, and controls (CMC), toxicology, and pharmacokinetics. Agility also provides executive level support and staffing, with the capability to provide CMOs or heads of project management, biostatistics and regulatory affairs, on a temporary or contract basis.
 
“Seasoned industry expertise is essential to deliver value to a sophisticated life science client, and we are very excited to have been able to assemble such a talented and experienced group of individuals. We can provide expert strategic and operational consulting support to our clients at all stages of clinical development,” said Ellen Morgan, chief executive officer of Agility. “Agility provides a centralized location where companies can get sound advice that is often vital to their clinical development plans with the ability to respond rapidly to changes and challenges.”